Communiqué de presse
Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
Thirty million doses expected to be delivered in 2020 and 2021, subject to regulatory approval or authorization Pfizer and […]